Skip to content

Inulin- and Butyrate-Mediated HIF-1α Butyrylation Prevent Diabetic Ferroptosis and Cardiomyopathy by Maintaining Iron Homeostasis.

Sep 2026 · Diabetes · 0 citations
Medicine

Abstract

ARTICLE HIGHLIGHTS Dysregulated iron metabolism and ferroptosis contribute to diabetic cardiomyopathy (DCM); however, the regulatory mechanisms and effective therapeutic strategies remain elusive. We sought to identify the role of hypoxia-inducible factor 1α (HIF-1α) in regulating myocardial iron homeostasis and ferroptosis in DCM, as well as evaluate the preventive effects of inulin on ferroptosis-induced DCM and elucidate its mechanism. Inulin-fermented butyrate activates the HIF-1α-ferritin heavy chain (FTH)/mitochondrial ferritin (FTMT) axis, alleviating cardiac ferroptosis and DCM, and stabilizes HIF-1α by promoting K190 Kbu modification and inhibiting ubiquitin-dependent degradation. Targeting the HIF-1α-FTH/FTMT axis via inulin, butyrate, or alternative approaches may represent a promising therapeutic strategy for alleviating DCM and other diabetes complications.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.